Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Michal M. Hoppe"'
Autor:
Michal M Hoppe, Patrick Jaynes, Joanna D Wardyn, Sai Srinivas Upadhyayula, Tuan Zea Tan, Stefanus Lie, Diana G Z Lim, Brendan N K Pang, Sherlly Lim, Joe P S Yeong, Anthony Karnezis, Derek S Chiu, Samuel Leung, David G Huntsman, Anna S Sedukhina, Ko Sato, Monique D Topp, Clare L Scott, Hyungwon Choi, Naina R Patel, Robert Brown, Stan B Kaye, Jason J Pitt, David S P Tan, Anand D Jeyasekharan
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 5, Pp 1-12 (2021)
Abstract Early relapse after platinum chemotherapy in epithelial ovarian cancer (EOC) portends poor survival. A‐priori identification of platinum resistance is therefore crucial to improve on standard first‐line carboplatin–paclitaxel treatment
Externí odkaz:
https://doaj.org/article/528aa4a3e7914e67822d83f66967eb8d
Autor:
Phaik Ju Teoh, Omer An, Tae-Hoon Chung, Thamil Vaiyapuri, Anandhkumar Raju, Michal M. Hoppe, Sabrina H. M. Toh, Wilson Wang, Ming Chun Chan, Melissa J. Fullwood, Anand D. Jeyasekharan, Vinay Tergaonkar, Leilei Chen, Henry Yang, Wee Joo Chng
Publikováno v:
Oncogene. 41:2106-2121
Recurrent cytogenetic abnormalities are the main hallmark of multiple myeloma (MM) and patients having 2 or more high-risk prognostic events are associated with extremely poor outcome. 17p13(del) and 1q21(gain) are critical and independent high-risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8cd865e6cac19e70e2f6bcab9960d34
https://doi.org/10.1038/s41388-022-02227-8
https://doi.org/10.1038/s41388-022-02227-8
Autor:
Jasmine Goh, Sanjay De Mel, Michal M. Hoppe, Masturah Bte Mohd Abdul Rashid, Xi Yun Zhang, Patrick Jaynes, Esther Ka Yan Ng, Nur’Atiqa Diana Binti Rahmat, null Jayalakshmi, Clementine Xin Liu, Limei Poon, Esther Chan, Joanne Lee, Yen Lin Chee, Liang Piu Koh, Lip Kun Tan, Teck Guan Soh, Yi Ching Yuen, Hoi-Yin Loi, Siok-Bian Ng, Xueying Goh, Donovan Eu, Stanley Loh, Sheldon Ng, Daryl Tan, Daryl Ming Zhe Cheah, Wan Lu Pang, Dachuan Huang, Shin Yeu Ong, Chandramouli Nagarajan, Jason Yongsheng Chan, Jeslin Chian Hung Ha, Lay Poh Khoo, Nagavalli Somasundaram, Tiffany Tang, Choon Kiat Ong, Wee-Joo Chng, Soon Thye Lim, Edward K. Chow, Anand D. Jeyasekharan
Publikováno v:
Science translational medicine. 14(667)
Although combination therapy is the standard of care for relapsed/refractory non-Hodgkin’s lymphoma (RR-NHL), combination treatment chosen for an individual patient is empirical, and response rates remain poor in individuals with chemotherapy-resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46b1b7c74cd4a099b1fd98c0c3cab1c0
https://pubmed.ncbi.nlm.nih.gov/36260690
https://pubmed.ncbi.nlm.nih.gov/36260690
Autor:
Upadhyayula S. Srinivas, Norbert S. C. Tay, Patrick Jaynes, Akshaya Anbuselvan, Gokula K. Ramachandran, Joanna D. Wardyn, Michal M. Hoppe, Phuong Mai Hoang, Yanfen Peng, Sherlly Lim, May Yin Lee, Praveen C. Peethala, Omer An, Akshay Shendre, Bryce W. Q. Tan, Sherlyn Jemimah, Manikandan Lakshmanan, Longyu Hu, Rekha Jakhar, Karishma Sachaphibulkij, Lina H. K. Lim, Shazib Pervaiz, Karen Crasta, Henry Yang, Patrick Tan, Chao Liang, Lena Ho, Vartika Khanchandani, Dennis Kappei, Wei Peng Yong, David S. P. Tan, Matteo Bordi, Silvia Campello, Wai Leong Tam, Christian Frezza, Anand D. Jeyasekharan
Publikováno v:
Oncogene. 41(13)
Inhibitors of the mitotic kinase PLK1 yield objective responses in a subset of refractory cancers. However, PLK1 overexpression in cancer does not correlate with drug sensitivity, and the clinical development of PLK1 inhibitors has been hampered by t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddca1ec5cc8283f632a7ab341ef4512d
https://pubmed.ncbi.nlm.nih.gov/35523948
https://pubmed.ncbi.nlm.nih.gov/35523948
Autor:
Upadhyayula S. Srinivas, Norbert S. C. Tay, Patrick Jaynes, Akshaya Anbuselvan, Gokula K. Ramachandran, Joanna D. Wardyn, Michal M. Hoppe, Phuong Mai Hoang, Yanfen Peng, Sherlly Lim, May Yin Lee, Praveen C. Peethala, Omer An, Akshay Shendre, Bryce W. Q. Tan, Sherlyn Jemimah, Manikandan Lakshmanan, Longyu Hu, Rekha Jakhar, Karishma Sachaphibulkij, Lina H. K. Lim, Shazib Pervaiz, Karen Crasta, Henry Yang, Patrick Tan, Chao Liang, Lena Ho, Vartika Khanchandani, Dennis Kappei, Wei Peng Yong, David S. P. Tan, Matteo Bordi, Silvia Campello, Wai Leong Tam, Christian Frezza, Anand D. Jeyasekharan
Publikováno v:
Oncogene. 41:3382-3382
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::251b05ecb86af440fe110b52509b6574
https://doi.org/10.1038/s41388-022-02338-2
https://doi.org/10.1038/s41388-022-02338-2
Autor:
Ng SB; 1 Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; 2 Department of Pathology, National University Hospital, National University Health System, Singapore.; 3 Cancer Science Institute of Singapore, National University of Singapore, Singapore., Fan S; 1 Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Choo SN; 1 Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; 2 Department of Pathology, National University Hospital, National University Health System, Singapore., Hoppe M; 3 Cancer Science Institute of Singapore, National University of Singapore, Singapore., Mai Phuong H; 3 Cancer Science Institute of Singapore, National University of Singapore, Singapore., De Mel S; 4 Department of Haematology-Oncology, National University Health System, Singapore., Jeyasekharan AD; 3 Cancer Science Institute of Singapore, National University of Singapore, Singapore.; 4 Department of Haematology-Oncology, National University Health System, Singapore.
Publikováno v:
SLAS technology [SLAS Technol] 2018 Jun; Vol. 23 (3), pp. 252-258. Date of Electronic Publication: 2017 Dec 14.